|
CHERP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.905030E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.559590E-02 |
| Normal-vs-Stage2 |
1.867190E-01 |
| Normal-vs-Stage3 |
2.516800E-01 |
| Normal-vs-Stage4 |
8.470200E-01 |
| Stage1-vs-Stage2 |
9.716800E-01 |
| Stage1-vs-Stage3 |
5.416500E-03 |
| Stage1-vs-Stage4 |
2.201200E-01 |
| Stage2-vs-Stage3 |
5.322200E-02 |
| Stage2-vs-Stage4 |
2.964600E-01 |
| Stage3-vs-Stage4 |
5.843600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.283350E-01 |
| Normal-vs-AfricanAmerican |
2.446600E-01 |
| Normal-vs-Asian |
7.755200E-01 |
| Caucasian-vs-AfricanAmerican |
9.506000E-01 |
| Caucasian-vs-Asian |
9.368600E-01 |
| AfricanAmerican-vs-Asian |
9.504800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.882400E-02 |
| Normal-vs-Female |
5.901200E-01 |
| Male-vs-Female |
1.689790E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.741800E-01 |
| Normal-vs-Extreme_Weight |
4.960300E-02 |
| Normal-vs-Obese |
8.781200E-01 |
| Normal-vs-Extreme_Obese |
2.046200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.826200E-01 |
| Normal_Weight-vs-Obese |
5.937400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.580000E-01 |
| Extreme_Weight-vs-Obese |
1.112000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.564800E-01 |
| Obese-vs-Extreme_Obese |
4.350000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.282070E-02 |
| Normal-vs-Age(41-60Yrs) |
8.538400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.583800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.433760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.315100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.792580E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.778100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.937400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.624300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.998200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.016600E-01 |
| Normal-VS-Type2 PRCC |
8.982300E-03 |
| Normal-VS-KIRP CIMP |
3.136800E-01 |
| Normal-VS-Unclassified PRCC |
3.529600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.570300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.350250E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.952400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.018300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.639000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.213980E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.527900E-02 |
| Normal-vs-N1 |
6.232000E-02 |
| Normal-vs-N2 |
5.773000E-01 |
| N0-vs-N1 |
1.140390E-03 |
| N0-vs-N2 |
7.323800E-01 |
| N1-vs-N2 |
2.621800E-01 |
|
|
